Before you sell to, join or invest in DeepCyte Inc.
MentionFox check on DeepCyte Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/deepcyte-inc-form-d-26000001
Check DeepCyte Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
DeepCyte Inc. filed a Form D with the Securities and Exchange Commission on 2026-01-29.
DeepCyte Inc. filed a Form D notice of an exempt securities offering with the SEC on January 29, 2026. The filing reports $1.45M sold. Its industry group is Business Services. It names THEODORE ALEXANDROV (Executive Officer) (SEC Form D, January 29, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like DeepCyte Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-01-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns DeepCyte Inc.
Free to see. No signup.
More on the people and the money behind DeepCyte Inc., from the filings we hold.
Business Services raises filed within 90 days of this one, largest first.
Get an email when DeepCyte Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when DeepCyte Inc. raises, hires or launches. No email unless you switch it on.
Watch DeepCyte Inc. →Get the full cited report on DeepCyte Inc.
What the filing shows about DeepCyte Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on DeepCyte Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives DeepCyte Inc.'s address as 221 W 9th St, Pmb 427, Wilmington, DE 19801.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
DeepCyte Inc. is a registered filer with the SEC (CIK 2107494) and has filed since 2026-01-29. 1 filing is on record, the latest on 2026-01-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
DeepCyte Inc.'s Form D of 2026-01-29 names THEODORE ALEXANDROV as its officers, directors or promoters.
Its new offerings report $1.45M sold across 1 offering, as its own filings state.
Trailing twelve months. 313 filings in Business Services, totalled by week. The dot is this raise, $1.45M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
DeepCyte combines single cell metabolomics with AI models to detect drug toxicity early. Reveal why cells turn toxic before drugs reach patients.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Theodore Alexandrov is named as Executive Officer on the Form D that DeepCyte Inc. filed with the SEC on 29 January 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-01-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about DeepCyte Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on DeepCyte Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DeepCyte Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist DeepCyte Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind DeepCyte Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-06 (deepcyte.bio).
Each opens in a new tab, filled in for DeepCyte Inc.. With no account yet, you sign up free and land on the result.
On these lists: Business services raises in Philadelphia
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/deepcyte-inc-form-d-26000001